Clinical Trials List
2009-02-15 - 2012-09-15
Phase III
Terminated16
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yenn-Jiang Lin Division of Cardiovascular Diseases
- Chern-En Chiang Division of Cardiovascular Diseases
- Li-Wei Lo Division of Cardiovascular Diseases
- Shih-Ann Chen Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳雅珮 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 王俊力 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 溫文才 Division of Cardiovascular Diseases
- Tsung-Hsien Lin Division of Cardiovascular Diseases
- 顏學偉 Division of Cardiovascular Diseases
- Hsiang Chun Lee Division of Cardiovascular Diseases
- Ye-Hsu Lu Division of Cardiovascular Diseases
- 李坤泰 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳文憲 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 葉同成 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- LIAN-YU LIN Division of Cardiovascular Diseases
- - - Division of Cardiovascular Diseases
- Yi-Chih Wang Division of Cardiovascular Diseases
- 張博淵 Division of Cardiovascular Diseases
- 賴凌平 Division of Cardiovascular Diseases
- Yen-Wen Wu Division of Cardiovascular Diseases
- 游治節 Division of Cardiovascular Diseases
- 林俊立 Division of Cardiovascular Diseases
- 蘇大成 Division of Cardiovascular Diseases
- CHIA-TI TSAI Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 邱俊仁 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
240 participants
-
Global
16500 participants